Pharmacokinetics of droloxifene and its metabolites in breast cancer patients.

Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.

Pharmacokinetics of perindopril and its metabolites in healthy volunteers.

Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.

Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.

Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer.

Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.

Estrogen metabolites and breast cancer.

European early phase II dose-finding study of droloxifene in advanced breast cancer.

Linking the population pharmacokinetics of tenofovir and its metabolites with its cellular uptake and metabolism.

Activity of tamoxifen and its metabolites on endocrine-dependent and endocrine-independent breast cancer cells.

Pharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model.

Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents.

Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer.

Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.

The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats.

Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.

Pharmacokinetics and Reversible Biotransformation of Sulfinpyrazone and Its Metabolites in Rabbits. II. Multiple-Dose Study.

Pharmacokinetics of omeprazole and its metabolites in three phases of menstrual cycle.

Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.

Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery.

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.

Pharmacokinetics of caffeine and its metabolites in horses after intravenous, intramuscular or oral administration.

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.

Suggest Documents

Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.

Pharmacokinetics of perindopril and its metabolites in healthy volunteers.

Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.

Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.

Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer.

Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.

Estrogen metabolites and breast cancer.

European early phase II dose-finding study of droloxifene in advanced breast cancer.

Linking the population pharmacokinetics of tenofovir and its metabolites with its cellular uptake and metabolism.

Activity of tamoxifen and its metabolites on endocrine-dependent and endocrine-independent breast cancer cells.

Pharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model.

Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents.

Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer.

Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.

The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats.

Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.

Pharmacokinetics and Reversible Biotransformation of Sulfinpyrazone and Its Metabolites in Rabbits. II. Multiple-Dose Study.

Pharmacokinetics of omeprazole and its metabolites in three phases of menstrual cycle.

Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.

Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery.

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.

Pharmacokinetics of caffeine and its metabolites in horses after intravenous, intramuscular or oral administration.

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.

Pharmacokinetics of droloxifene and its metabolites in breast cancer patients.

Recommend Documents

Follow Us